semaglutide vs gastric sleeve Bariatric Surgery Outperforms GLP-1s in Weight Loss Semaglutide vs Bariatric Surgery: 2026

ATTAIN-2: obesit con diabete di tipo 2 ATTAIN-2 (Horn et al., 2025) ha replicato lo stesso disegno su 1613 pazienti con BMI 27 e diabete di tipo 2, con emoglobina glicata fra 7% e 10% al basale, in terapia con un massimo di tre antidiabetici orali o solo dieta

Month 3 and beyond: Many patients report having almost no side effects, even as they continue to lose weight

The short flow relies heavily on the single disqualification gate and the clinician review after checkout to fill in the depth

Oral semaglutide (Rybelsus) can increase levothyroxine exposure and requires additional thyroid function monitoring and dose separation